IL-1β is a potent inflammatory cytokine affecting dendritic cells (DCs), NK, and T cells30,51,86,87, whereas IL-18, with its ability to activate NK and T cells, has shown promise in preclinical cancer immunotherapy studies34,35. Here, IL18 is linked to cancer.